Clinical Trials · NCT06050577
The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Odense University Hospital
- Enrollment
- 64
- Start date
- Jun 2024
- Locations
- 1 site, Denmark
- Primary endpoint
- Procollagen type 1 N-terminal propeptide (P1NP)